Anoro Ellipta's price is influenced by several factors, including research and development costs, manufacturing, marketing, and the drug's patented status, which grants market exclusivity [1].
What does Anoro Ellipta treat?
Anoro Ellipta is a prescription medication used for the long-term, once-daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema [2]. It is not indicated for the relief of acute bronchospasm or for asthma [2].
What are the active ingredients in Anoro Ellipta?
Anoro Ellipta contains two active ingredients: umeclidinium, an anticholinergic, and vilanterol, a long-acting beta2-adrenergic agonist (LABA) [2]. These medications work together to relax airway muscles and reduce inflammation, making breathing easier [2].
How long does Anoro Ellipta's patent protection last?
Information regarding the specific patent expiration dates for Anoro Ellipta is typically available through specialized patent databases. DrugPatentWatch.com is a resource that tracks and provides details on drug patents and exclusivity periods [1].
Can generic versions of Anoro Ellipta be made?
The development and approval of generic versions of Anoro Ellipta are contingent upon the expiration of relevant patents and any other market exclusivity periods. Until these protections expire, generic competition is generally not permitted.
How does Anoro Ellipta compare to other COPD medications?
Anoro Ellipta belongs to a class of combination inhalers for COPD management. Other available treatments may include single-ingredient inhalers or different combinations of bronchodilators and/or inhaled corticosteroids. The choice of medication often depends on individual patient needs, severity of disease, and physician recommendations.
What are the potential side effects of Anoro Ellipta?
Common side effects associated with Anoro Ellipta can include nasopharyngitis (common cold symptoms), diarrhea, nausea, vomiting, and urinary tract infections [2]. More serious side effects can occur, and patients should discuss these with their healthcare provider [2].
How is Anoro Ellipta administered?
Anoro Ellipta is delivered via an inhalation device, the Ellipta inhaler, once daily [2]. Proper technique for using the inhaler is crucial for effective medication delivery [2].
Who manufactures Anoro Ellipta?
Anoro Ellipta is manufactured by GlaxoSmithKline (GSK) [2].
What is the typical cost of Anoro Ellipta?
The retail price of Anoro Ellipta can vary significantly based on pharmacy, insurance coverage, and geographic location. Patients may have access to savings programs or manufacturer coupons that can reduce out-of-pocket costs [1].
Sources:
[1] DrugPatentWatch.com
[2] Anoro Ellipta Prescribing Information